375 related articles for article (PubMed ID: 15656784)
1. Novel molecular approaches to cystic fibrosis gene therapy.
Lee TW; Matthews DA; Blair GE
Biochem J; 2005 Apr; 387(Pt 1):1-15. PubMed ID: 15656784
[TBL] [Abstract][Full Text] [Related]
2. Vector-specific complementation profiles of two independent primary defects in cystic fibrosis airways.
Zhang Y; Jiang Q; Dudus L; Yankaskas JR; Engelhardt JF
Hum Gene Ther; 1998 Mar; 9(5):635-48. PubMed ID: 9551612
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy for cystic fibrosis: which postman, which box?
Middleton PG; Alton EW
Thorax; 1998 Mar; 53(3):197-9. PubMed ID: 9659356
[TBL] [Abstract][Full Text] [Related]
4. Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis.
Zabner J; Ramsey BW; Meeker DP; Aitken ML; Balfour RP; Gibson RL; Launspach J; Moscicki RA; Richards SM; Standaert TA
J Clin Invest; 1996 Mar; 97(6):1504-11. PubMed ID: 8617884
[TBL] [Abstract][Full Text] [Related]
5. Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. I. Methods, safety, and clinical implications.
Joseph PM; O'Sullivan BP; Lapey A; Dorkin H; Oren J; Balfour R; Perricone MA; Rosenberg M; Wadsworth SC; Smith AE; St George JA; Meeker DP
Hum Gene Ther; 2001 Jul; 12(11):1369-82. PubMed ID: 11485629
[TBL] [Abstract][Full Text] [Related]
6. Gene therapy for cystic fibrosis lung disease: current status and future perspectives.
Rosenecker J; Huth S; Rudolph C
Curr Opin Mol Ther; 2006 Oct; 8(5):439-45. PubMed ID: 17078386
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy for cystic fibrosis.
Davies JC; Alton EW
Proc Am Thorac Soc; 2010 Nov; 7(6):408-14. PubMed ID: 21030522
[TBL] [Abstract][Full Text] [Related]
8. [Aerosol administration of a replication defective recombinant adenovirus expressing normal human cDNA-CFTR in the respiratory tractus in patients with cystic fibrosis].
Bellon G; Calmard L; Thouvenot D; Levrey H; Jagneaux V; Poitevin F; Malcus C; Accart N; Séné C; Layani MP; Aymard M; Bienvenu J; Courtney M; Döring G; Gilly B; Gilly R; Lamy D; Morel Y; Paulin C; Perraud F; Rodillon L; So S; Touraine F; Schatz C; Pavirani A
C R Seances Soc Biol Fil; 1996; 190(1):109-42. PubMed ID: 8881273
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus 5-fiber 35 chimeric vector mediates efficient apical correction of the cystic fibrosis transmembrane conductance regulator defect in cystic fibrosis primary airway epithelia.
Granio O; Ashbourne Excoffon KJ; Henning P; Melin P; Norez C; Gonzalez G; Karp PH; Magnusson MK; Habib N; Lindholm L; Becq F; Boulanger P; Zabner J; Hong SS
Hum Gene Ther; 2010 Mar; 21(3):251-69. PubMed ID: 19788389
[TBL] [Abstract][Full Text] [Related]
10. Is gene therapy in cystic fibrosis a realistic expectation?
McElvaney NG
Curr Opin Pulm Med; 1996 Nov; 2(6):466-71. PubMed ID: 9363187
[TBL] [Abstract][Full Text] [Related]
11. A phase I study of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator gene to a lung segment of individuals with cystic fibrosis.
Zuckerman JB; Robinson CB; McCoy KS; Shell R; Sferra TJ; Chirmule N; Magosin SA; Propert KJ; Brown-Parr EC; Hughes JV; Tazelaar J; Baker C; Goldman MJ; Wilson JM
Hum Gene Ther; 1999 Dec; 10(18):2973-85. PubMed ID: 10609658
[TBL] [Abstract][Full Text] [Related]
12. Current status and future directions of gene and cell therapy for cystic fibrosis.
Griesenbach U; Alton EW
BioDrugs; 2011 Apr; 25(2):77-88. PubMed ID: 21443272
[TBL] [Abstract][Full Text] [Related]
13. Liposomes and viruses for gene therapy of cystic fibrosis.
Coutelle C; Williamson R
J Aerosol Med; 1996; 9(1):79-88. PubMed ID: 10160212
[TBL] [Abstract][Full Text] [Related]
14. Advances in cystic fibrosis gene therapy.
Griesenbach U; Geddes DM; Alton EW
Curr Opin Pulm Med; 2004 Nov; 10(6):542-6. PubMed ID: 15510064
[TBL] [Abstract][Full Text] [Related]
15. The prospects for gene therapy in cystic fibrosis.
Alton E; Geddes D
Curr Opin Pulm Med; 1995 Nov; 1(6):471-7. PubMed ID: 9363084
[TBL] [Abstract][Full Text] [Related]
16. A double-blind, placebo controlled, dose ranging study to evaluate the safety and biological efficacy of the lipid-DNA complex GR213487B in the nasal epithelium of adult patients with cystic fibrosis.
Knowles MR; Noone PG; Hohneker K; Johnson LG; Boucher RC; Efthimiou J; Crawford C; Brown R; Schwartzbach C; Pearlman R
Hum Gene Ther; 1998 Jan; 9(2):249-69. PubMed ID: 9472784
[TBL] [Abstract][Full Text] [Related]
17. Gene therapy for cystic fibrosis by means of aerosol.
Rochat T; Morris MA
J Aerosol Med; 2002; 15(2):229-35. PubMed ID: 12184873
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy for cystic fibrosis using E1-deleted adenovirus: a phase I trial in the nasal cavity. The University of North Carolina at Chapel Hill.
Boucher RC; Knowles MR; Johnson LG; Olsen JC; Pickles R; Wilson JM; Engelhardt J; Yang Y; Grossman M
Hum Gene Ther; 1994 May; 5(5):615-39. PubMed ID: 7519885
[TBL] [Abstract][Full Text] [Related]
19. Progress towards gene therapy for cystic fibrosis.
Tate S; Elborn S
Expert Opin Drug Deliv; 2005 Mar; 2(2):269-80. PubMed ID: 16296753
[TBL] [Abstract][Full Text] [Related]
20. Cystic fibrosis, vector-mediated gene therapy, and relevance of toll-like receptors: a review of problems, progress, and possibilities.
Atkinson TJ
Curr Gene Ther; 2008 Jun; 8(3):201-7. PubMed ID: 18537594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
